| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/13/2013 | CN102961748A Method for reducing intraocular pressure by using gap junction blocker |
| 03/13/2013 | CN102961746A Use of tnf inhibitor for treatment of erosive polyarthritis |
| 03/13/2013 | CN102056630B Stabilizer for lymph vessel |
| 03/13/2013 | CN102018693B Topical co-enzyme Q10 formulations and methods of use |
| 03/13/2013 | CN101980708B Imidazoquinolines and pyrimidine derivatives as potent modulators of VEGF-driven angiogenic processes |
| 03/13/2013 | CN101903045B Pharmaceutical composition for treatment of cataract |
| 03/13/2013 | CN101633636B Peptidomimetic protease inhibitors |
| 03/13/2013 | CN101605529B Stable formulations, and methods of their preparation and use |
| 03/13/2013 | CN101513391B Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
| 03/12/2013 | US8394930 Growth factor isoform |
| 03/12/2013 | US8394929 Nogo receptor-mediated blockade of axonal growth |
| 03/12/2013 | US8394854 Use of L-carnitine for the treatment of cardiovascular diseases |
| 03/12/2013 | US8394849 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 03/12/2013 | US8394757 Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 03/12/2013 | US8394397 Adhesive antineoplastic compositions |
| 03/12/2013 | US8394372 Stabilized protease composition |
| 03/12/2013 | US8394361 Stable surfactant compositions for suspending components |
| 03/12/2013 | US8394141 Connective-tissue-based or dermal-tissue-based grafts/implants |
| 03/12/2013 | CA2619779C Use of a pde5 inhibitor for treating and preventing hypopigmentary disorders |
| 03/12/2013 | CA2542332C Immunomodulating compositions and uses therefor |
| 03/12/2013 | CA2530381C Combination product comprising an antagonist or inverse agonist of histamine receptor h<sb>3 </sb>and an antipsychotic or antidepressant agent, and use thereof for the preparationof a medicament that prevents the adverse effects of psychotropic drugs |
| 03/12/2013 | CA2480199C Fp-ghrelin |
| 03/12/2013 | CA2473927C Methods and compositions for treating polycystic ovary syndrome |
| 03/12/2013 | CA2468888C Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 03/12/2013 | CA2464092C Electroprocessing in drug delivery and cell encapsulation |
| 03/12/2013 | CA2407910C Antibodies that immunospecifically bind to blys |
| 03/12/2013 | CA2405307C Application of substances acting as cascade inhibitors of the raf/mek/erk signaling cascade for the production of a drug against infections by dna and rna viruses |
| 03/12/2013 | CA2285923C Methods and compositions for treating inflammatory bowel disease |
| 03/07/2013 | WO2013033688A1 Treatment of cancer |
| 03/07/2013 | WO2013033618A1 Lipid compositions with high dha content |
| 03/07/2013 | WO2013033319A2 A cluster of neutralizing antibodies to hepatitis c virus |
| 03/07/2013 | WO2013033283A1 Improving systemic glucose tolerance in type-2 diabetes |
| 03/07/2013 | WO2013031882A1 Vaccine preparation for cancer treatment |
| 03/07/2013 | WO2013031831A1 Method for improving therapy for autoimmune diseases such as rheumatoid arthritis |
| 03/07/2013 | WO2013031729A1 Prophylactic/therapeutic agent for cardiovascular complications of diabetes |
| 03/07/2013 | WO2013031620A1 Osteogenesis promoter and use thereof |
| 03/07/2013 | WO2013030512A1 Use of compositions having a low polyamine content in the prevention or treatment of adverse effects linked to cancer treatment |
| 03/07/2013 | WO2012135095A9 S1p antagonists as adjunct ocular hypotensives |
| 03/07/2013 | US20130059931 Activation induced deaminase (aid) |
| 03/07/2013 | US20130059877 Treatment of solid tumors with rapamycin derivatives |
| 03/07/2013 | US20130059774 Efflux pump inhibitors |
| 03/07/2013 | DE10213051B4 Substituierte 4-Aminocyclohexanole Substituted 4-aminocyclohexanols |
| 03/07/2013 | CA2847332A1 Vaccine preparation for cancer treatment |
| 03/07/2013 | CA2847001A1 Use of compositions having a low polyamine content in the prevention or treatment of adverse effects linked to cancer treatment |
| 03/07/2013 | CA2846845A1 Methods and compositions for promoting glucose homeostasis |
| 03/06/2013 | EP2565278A1 Method for the delivery of oligonucleotides |
| 03/06/2013 | EP2564872A1 Combination of mazindol in the treatment of attention-deficit/hyperactivity disorder |
| 03/06/2013 | EP2564871A1 Therapeutic Agent for Migraine |
| 03/06/2013 | EP2564870A1 Pharmaceutical composition for treatment and prevention of herpesvirus infections |
| 03/06/2013 | EP2564856A1 Treatment of heart failure in non-human mammals with an aldosterone antagonist |
| 03/06/2013 | EP2564855A1 Treatment of heart failure in non-human mammals with an aldosterone antagonist |
| 03/06/2013 | EP2564854A1 Treatment of heart failure in non-human mammals with an aldosterone antagonist |
| 03/06/2013 | EP2564846A1 Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with anti-cd20 agents |
| 03/06/2013 | EP2563384A2 Immunogenic compositions and methods for treating neoplasia |
| 03/06/2013 | EP2563371A1 Anti-bacterial applications of poly -n-acetylglucosamine nanofibers |
| 03/06/2013 | EP2563369A2 Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof |
| 03/06/2013 | EP2563364A1 Combination of carmoterol and fluticasone for use in the treatment respiratory diseases |
| 03/06/2013 | EP2563356A2 A composition for skin sanitization and protection and method of its use |
| 03/06/2013 | EP2563354A1 Metal entrapped bioactive composites |
| 03/06/2013 | EP2563348A1 New combination therapy in treatment of oncological and fibrotic diseases |
| 03/06/2013 | EP2563119A1 Method and medication for prevention and treatment of ocular hypertension and glaucoma |
| 03/06/2013 | EP1792927B1 Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient |
| 03/06/2013 | CN202761743U Hollow, ventilating and double-layer traditional Chinese medicine suppository for treating rhinitis |
| 03/06/2013 | CN102958540A Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations |
| 03/06/2013 | CN102958518A Combination of a phosphoinositide 3-kinase inhibitor and an antidiabetic compound for use in the treatment of proliferative diseases |
| 03/06/2013 | CN102952849A Application of protein coded by gene LIMG and antibody thereof in breast cancer diagnosis and/or treatment |
| 03/06/2013 | CN102949726A Medicinal composition |
| 03/06/2013 | CN102949725A Injection medicine composition containing glucocorticoid and NOS (nitric oxide synthase) inhibitor |
| 03/06/2013 | CN102949724A Inhalation medicine composition containing glucocorticoid and NOS (nitric oxide synthase) inhibitor |
| 03/06/2013 | CN102949723A Medicinal composition containing glucocorticoid and NOS (Nitric Oxide Synthase) inhibitor for treating skin inflammation |
| 03/06/2013 | CN102949722A Novel pharmaceutical composition based on p38 inhibitor and cell growth factor |
| 03/06/2013 | CN102949721A Transdermal absorption pharmaceutical composition containing testosterone and NOS inhibitor |
| 03/06/2013 | CN102174777B Method of using aldehyde-functionalized polymers to enhance paper machine dewatering |
| 03/06/2013 | CN102046201B Inhibitor of analgesic tolerance |
| 03/06/2013 | CN101883566B Mequitazine for treating or preventing pathologies involving histamine h4 receptors |
| 03/06/2013 | CN101010101B Composition comprising protein material and non-oxidizable fatty acid entities |
| 03/05/2013 | US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression |
| 03/05/2013 | US8389570 Hydroxamates as therapeutic agents |
| 03/05/2013 | US8389497 Using of alkylphosphocholines for the manufacture of a drug product for the therapy of benign and malignant oncoses |
| 03/05/2013 | US8389496 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 03/05/2013 | US8389495 Olioodeoxynucleotide and its use to induce an immune response |
| 03/05/2013 | US8389484 Methods for targeting RNA molecules |
| 03/05/2013 | US8389043 Preparation for restenosis prevention |
| 03/05/2013 | US8389017 Calcium-containing structures and methods of making and using the same |
| 03/05/2013 | US8389011 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 03/05/2013 | US8389006 Pharmaceutical compositions of adsorbates of amorphous drug |
| 03/05/2013 | US8389005 Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance |
| 03/05/2013 | US8388990 Acidified chlorite compositions containing nitrogenous stabilizers and systems and methods related thereto |
| 03/05/2013 | US8388980 Yeast-based therapeutic for chronic hepatitis C infection |
| 03/05/2013 | US8388977 Diagnosis of macrophage mediated disease |
| 03/05/2013 | US8388976 Polypeptide specifically binding to vascular endothelial growth factor, fusion protein including polypeptide, and methods therefor |
| 03/05/2013 | US8388966 Combination treatment of pancreatic cancer |
| 03/05/2013 | US8388935 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 02/28/2013 | WO2013028505A1 Combination cancer therapy of hsp90 inhibitor with antimetabolite |
| 02/28/2013 | WO2013027680A1 Drug for preventing exacerbation of malignant tumor, comprising combination of natriuretic peptide receptor gc-a agonist and gc-b agonist |
| 02/28/2013 | WO2013026558A2 Combined therapeutic agent |
| 02/28/2013 | WO2013026557A1 Vasoconstrictor-containing agent for combination therapy |
| 02/28/2013 | WO2013026268A1 Tumor chemotherapeutic drug formulation and preparation method thereof |
| 02/28/2013 | WO2012117385A3 Liposome formulation comprising an anti-tumour active substance, method for its preparation and pharmaceutical compositions comprising it |
| 02/28/2013 | US20130053618 Radiation sensitive liposomes |